QQQ   390.19 (+0.26%)
AAPL   190.40 (+0.32%)
MSFT   382.70 (+1.08%)
META   338.99 (+1.28%)
GOOGL   137.20 (+0.58%)
AMZN   147.03 (-0.47%)
TSLA   246.72 (+4.51%)
NVDA   478.21 (-0.87%)
NIO   7.21 (+0.28%)
BABA   76.72 (-1.04%)
AMD   122.01 (-0.52%)
T   16.18 (-0.19%)
F   10.39 (+0.48%)
MU   76.12 (-1.79%)
CGC   0.54 (-1.82%)
GE   118.85 (-0.93%)
DIS   92.50 (-2.81%)
AMC   6.70 (-1.47%)
PFE   29.69 (-1.49%)
PYPL   58.47 (+3.69%)
XOM   103.90 (-0.06%)
QQQ   390.19 (+0.26%)
AAPL   190.40 (+0.32%)
MSFT   382.70 (+1.08%)
META   338.99 (+1.28%)
GOOGL   137.20 (+0.58%)
AMZN   147.03 (-0.47%)
TSLA   246.72 (+4.51%)
NVDA   478.21 (-0.87%)
NIO   7.21 (+0.28%)
BABA   76.72 (-1.04%)
AMD   122.01 (-0.52%)
T   16.18 (-0.19%)
F   10.39 (+0.48%)
MU   76.12 (-1.79%)
CGC   0.54 (-1.82%)
GE   118.85 (-0.93%)
DIS   92.50 (-2.81%)
AMC   6.70 (-1.47%)
PFE   29.69 (-1.49%)
PYPL   58.47 (+3.69%)
XOM   103.90 (-0.06%)
QQQ   390.19 (+0.26%)
AAPL   190.40 (+0.32%)
MSFT   382.70 (+1.08%)
META   338.99 (+1.28%)
GOOGL   137.20 (+0.58%)
AMZN   147.03 (-0.47%)
TSLA   246.72 (+4.51%)
NVDA   478.21 (-0.87%)
NIO   7.21 (+0.28%)
BABA   76.72 (-1.04%)
AMD   122.01 (-0.52%)
T   16.18 (-0.19%)
F   10.39 (+0.48%)
MU   76.12 (-1.79%)
CGC   0.54 (-1.82%)
GE   118.85 (-0.93%)
DIS   92.50 (-2.81%)
AMC   6.70 (-1.47%)
PFE   29.69 (-1.49%)
PYPL   58.47 (+3.69%)
XOM   103.90 (-0.06%)
QQQ   390.19 (+0.26%)
AAPL   190.40 (+0.32%)
MSFT   382.70 (+1.08%)
META   338.99 (+1.28%)
GOOGL   137.20 (+0.58%)
AMZN   147.03 (-0.47%)
TSLA   246.72 (+4.51%)
NVDA   478.21 (-0.87%)
NIO   7.21 (+0.28%)
BABA   76.72 (-1.04%)
AMD   122.01 (-0.52%)
T   16.18 (-0.19%)
F   10.39 (+0.48%)
MU   76.12 (-1.79%)
CGC   0.54 (-1.82%)
GE   118.85 (-0.93%)
DIS   92.50 (-2.81%)
AMC   6.70 (-1.47%)
PFE   29.69 (-1.49%)
PYPL   58.47 (+3.69%)
XOM   103.90 (-0.06%)

OPKO Health (OPK) News Today

$1.56
-0.01 (-0.64%)
(As of 11/28/2023 ET)
Compare
Today's Range
$1.52
$1.57
50-Day Range
$1.23
$1.66
52-Week Range
$1.00
$2.24
Volume
1.30 million shs
Average Volume
2.93 million shs
Market Capitalization
$1.21 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$3.85
SourceHeadline
finance.yahoo.com logoBioReference Health and Prognos Health Collaborate to Advance Precision Medicine and Testing
finance.yahoo.com - November 28 at 8:10 AM
MarketBeat logoFY2023 Earnings Estimate for OPKO Health, Inc. (NASDAQ:OPK) Issued By Zacks Research
americanbankingnews.com - November 25 at 1:26 AM
finance.yahoo.com logoPhillip Frost Spends US$1.3m On OPKO Health Stock
finance.yahoo.com - November 15 at 9:50 AM
fool.com logoOpko Health (FRA: XCY)
fool.com - November 10 at 12:58 PM
markets.businessinsider.com logoOptimistic Future Prospects and Financial Performance Bolster Buy Rating for Opko Health
markets.businessinsider.com - November 8 at 11:15 PM
markets.businessinsider.com logoOpko Health Maintains Buy Rating Amid Promising Q3 Results and Global Growth Hormone Expansion
markets.businessinsider.com - November 8 at 1:53 AM
finanznachrichten.de logoOPKO Health, Inc.: OPKO Health Reports Third Quarter 2023 Business Highlights and Financial Results
finanznachrichten.de - November 7 at 9:48 AM
finance.yahoo.com logoOPKO Health (OPK) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
finance.yahoo.com - November 6 at 11:50 PM
finance.yahoo.com logoOPKO Health Reports Third Quarter 2023 Business Highlights and Financial Results
finance.yahoo.com - November 6 at 6:47 PM
finance.yahoo.com logoOPKO Health Inc (OPK) Reports Third Quarter 2023 Financial Results
finance.yahoo.com - November 6 at 6:47 PM
markets.businessinsider.com logoOpko Health earnings preview: what Wall Street is expecting
markets.businessinsider.com - November 5 at 2:03 PM
benzinga.com logoEarnings Preview: OPKO Health
benzinga.com - November 3 at 5:41 PM
finance.yahoo.com logoNew Clinical Data on OPKO Health’s RAYALDEE® (ER Calcifediol) Presented at Kidney Week 2023
finance.yahoo.com - November 2 at 3:40 PM
finance.yahoo.com logoOPKO Health to Report Third Quarter 2023 Financial Results on November 6, 2023
finance.yahoo.com - October 31 at 9:57 AM
finanznachrichten.de logoOPKO Health, Inc.: OPKO Health to Present New Clinical Data on Rayaldee (ER Calcifediol) at Kidney Week 2023
finanznachrichten.de - October 26 at 10:18 PM
finance.yahoo.com logoOPKO Health to Present New Clinical Data on Rayaldee (ER Calcifediol) at Kidney Week 2023
finance.yahoo.com - October 25 at 8:42 PM
seekingalpha.com logoOPKO Health: FDA Approval To Save The Company
seekingalpha.com - October 20 at 1:30 PM
finance.yahoo.com logoInsiders' US$4.78m Investments In Red Following OPKO Health's US$139m Dip In Market Value
finance.yahoo.com - October 17 at 8:48 AM
finance.yahoo.com logoNextPlat's Florida E-Commerce Development Program to Launch the Online Sales of OPKO Healthcare Products in China on Alibaba's Tmall Global
finance.yahoo.com - October 12 at 11:35 AM
finance.yahoo.com logoOPKO Health (OPK) Gets BARDA Contract to Combat Antibody Threats
finance.yahoo.com - October 6 at 7:13 PM
marketbeat.com logoAE Wealth Management LLC Increases Holdings in OPKO Health, Inc. (NASDAQ:OPK)
marketbeat.com - September 30 at 4:13 AM
finanznachrichten.de logoOPKO Health, Inc.: ModeX Therapeutics Secures BARDA Contract to Develop Novel Multispecific Antibodies Against Viral Infectious Disease Threats
finanznachrichten.de - September 29 at 9:00 PM
finance.yahoo.com logoOPKO Health Inc (OPK): A Deep Dive into Its Performance Potential
finance.yahoo.com - September 29 at 3:59 PM
finance.yahoo.com logoOPKO Health (OPK) - A Fairly Valued Stock with Room for Growth?
finance.yahoo.com - September 28 at 11:46 PM
marketwatch.com logoModeX Therapeutics Awarded Contract to Address Public Health Threat From Viral Diseases
marketwatch.com - September 28 at 6:46 PM
finance.yahoo.com logoModeX Therapeutics Secures BARDA Contract to Develop Novel Multispecific Antibodies Against Viral Infectious Disease Threats
finance.yahoo.com - September 28 at 6:46 PM
finance.yahoo.com logoWith 43% ownership, insiders at OPKO Health, Inc. (NASDAQ:OPK) are pretty optimistic and have been buying recently
finance.yahoo.com - September 20 at 1:39 PM
markets.businessinsider.com logoEntera Collaborates With OPKO To Develop Oral Peptide Tablets For Obesity, Intestinal Malabsorption
markets.businessinsider.com - September 12 at 5:42 PM
finance.yahoo.com logoEntera Bio Announces Collaboration with OPKO Biologics to Develop Oral Peptide Tablet Formulations for Obesity and Intestinal Malabsorption Syndromes
finance.yahoo.com - September 12 at 8:49 AM
thestreet.com logoOPKO Health (OPK) Stock Falling After Bio-Reference Labs Acquisition
thestreet.com - September 9 at 3:03 PM
marketbeat.com logoCitigroup Inc. Sells 633,536 Shares of OPKO Health, Inc. (NASDAQ:OPK)
marketbeat.com - September 7 at 4:27 AM
benzinga.com logoEsoteric Testing Market Poised to Touch $36.3 Billion by 2026- Exclusive Report by MarketsandMarkets™
benzinga.com - August 31 at 11:23 PM
marketbeat.com logoOPKO Health, Inc. (NASDAQ:OPK) CEO Phillip Md Et Al Frost Buys 100,000 Shares
marketbeat.com - August 18 at 7:29 AM
marketbeat.com logoOPKO Health, Inc. Expected to Post FY2023 Earnings of ($0.21) Per Share (NASDAQ:OPK)
marketbeat.com - August 9 at 9:02 AM
finance.yahoo.com logoOPKO Health (OPK) Q2 Earnings and Revenues Top Estimates
finance.yahoo.com - August 8 at 9:57 AM
markets.businessinsider.com logoOpko Health (OPK) Receives a Buy from H.C. Wainwright
markets.businessinsider.com - August 7 at 9:18 AM
marketbeat.com logoOPKO Health (NASDAQ:OPK) Announces Quarterly Earnings Results, Beats Expectations By $0.04 EPS
marketbeat.com - August 4 at 10:51 PM
markets.businessinsider.com logoBarrington Reaffirms Their Buy Rating on Opko Health (OPK)
markets.businessinsider.com - August 4 at 7:14 PM
marketbeat.com logoOPKO Health (NASDAQ:OPK) Shares Gap Up After Strong Earnings
marketbeat.com - August 4 at 11:19 AM
finance.yahoo.com logoOpko Health (OPK) Q2 2023 Earnings Call Transcript
finance.yahoo.com - August 4 at 4:20 AM
finance.yahoo.com logoOPKO Health (OPK) Reports Q2 Loss, Tops Revenue Estimates
finance.yahoo.com - August 3 at 11:20 PM
msn.com logoOPKO Health GAAP EPS of -$0.03 beats by $0.04, revenue of $265.4M beats by $63.43M
msn.com - August 3 at 6:18 PM
finance.yahoo.com logoOPKO Health Reports Second Quarter 2023 Business Highlights and Financial Results
finance.yahoo.com - August 3 at 6:18 PM
benzinga.com logoA Preview Of OPKO Health's Earnings
benzinga.com - August 2 at 8:21 PM
msn.com logoOPKO Health: Improving Profitability Should Drive Shares Forward Post Q2 Earnings
msn.com - July 31 at 4:17 PM
finance.yahoo.com logoOPKO Health to Report Second Quarter 2023 Financial Results on August 3, 2023
finance.yahoo.com - July 25 at 11:29 PM
finance.yahoo.com logoOPKO Health (NASDAQ:OPK) investors are sitting on a loss of 61% if they invested three years ago
finance.yahoo.com - July 23 at 9:13 AM
marketbeat.com logoMarketBeat Week in Review – 7/17 - 7/21 (OPK)
marketbeat.com - July 22 at 7:00 AM
marketbeat.com logoOPKO Health is the Little Giant of Diversified Healthcare
marketbeat.com - July 19 at 7:14 AM
marketbeat.com logoStockNews.com Lowers OPKO Health (NASDAQ:OPK) to Sell
marketbeat.com - July 7 at 1:29 PM
Get OPKO Health News Delivered to You Automatically

Sign up to receive the latest news and ratings for OPK and its competitors with MarketBeat's FREE daily newsletter.



OPK Media Mentions By Week

OPK Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

OPK
News Sentiment

0.02

0.88

Average
Medical
News Sentiment

OPK News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

OPK Articles
This Week

6

3

OPK Articles
Average Week

Get OPKO Health News Delivered to You Automatically

Sign up to receive the latest news and ratings for OPK and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:OPK) was last updated on 11/28/2023 by MarketBeat.com Staff

My Account -